Stopping the spread of COVID-19 variants
COVID-19 vaccines
When a virus is widely circulating in a population and causing many infections, the likelihood of the virus mutating increases. The more opportunities a virus has to spread, the more it replicates – and the more opportunities it has to undergo changes.
Stopping the spread at the source remains key. Current measures to reduce transmission – including frequent hand washing, wearing a mask, physi...
Ver más detalles
Betacoronavirus/genética, Infecciones por Coronavirus/genética, Neumonía Viral/genética, Pandemias/prevención & control, Comunicación en Salud, Mutación/genética, COVID-19
Safety of COVID-19 vaccines: what we need to know
COVID-19 vaccines
As the world rolls out COVID-19 vaccines, many people are asking what to expect – in particular, are these vaccines safe? The answer is yes, but here’s a bit more information you may find useful.
Ver más detalles
Betacoronavirus/inmunología, Infecciones por Coronavirus/inmunología, Neumonía Viral/inmunología, Pandemias/prevención & control, Comunicación en Salud, Vacunas Virales/inmunología, COVID-19
Equitable access to COVID-19 vaccines
COVID-19 vaccines
Ver más detalles
Betacoronavirus/inmunología, Infecciones por Coronavirus/inmunología, Neumonía Viral/inmunología, Pandemias/prevención & control, Vacunas Virales/provisión & distribución, Acceso a Medicamentos Esenciales y Tecnologías Sanitarias, COVID-19
How COVID-19 vaccines are able to be developed so fast?
COVID-19 vaccines
WHO Chief Scientis, Dr Soumya Swaminathan, explains why COVID-19 vaccines are able to be developed so fast.
Ver más detalles
Betacoronavirus/inmunología, Infecciones por Coronavirus/inmunología, Neumonía Viral/inmunología, Pandemias/prevención & control, Comunicación en Salud, Vacunas Virales/inmunología, COVID-19
10 days, 20 countries, more than 10 million doses of COVID-19 vaccines: COVAX rollout is here!
COVID-19 vaccines
#COVAX has delivered over 20M #COVID19 vaccine doses to 20 countries. In the next week, it will deliver 14.4M doses to a further 31 countries. This is encouraging progress, but the volume of doses being distributed through COVAX is still relatively small.
Ver más detalles
Betacoronavirus/inmunología, Infecciones por Coronavirus/inmunología, Neumonía Viral/inmunología, Pandemias/prevención & control, Vacunas Virales/provisión & distribución, Programas de Inmunización/organización & administración, COVID-19, Covax
What causes a virus to change and how to stop stronger COVID-19 variants from emerging
COVID-19 vaccines
When a virus is widely circulating in a population and causing many infections, the likelihood of the virus mutating increases. The more opportunities a virus has to spread, the more it replicates – and the more opportunities it has to undergo changes.
Stopping the spread at the source remains key. Current measures to reduce transmission – including frequent hand washing, wearing a mask, physi...
Ver más detalles
Betacoronavirus/genética, Infecciones por Coronavirus/genética, Neumonía Viral/genética, Pandemias/prevención & control, Comunicación en Salud, Mutación/genética, COVID-19
To stop stronger COVID-19 variants from emerging we need to work together globally
COVID-19 vaccines
Ensuring equitable access to COVID-19 vaccines is more critical than ever to address the evolving pandemic. If some parts of the world eliminate the virus while it spreads widely in other areas, we all run the risk of stronger strains evolving. We’re only safe when everyone is safe.
Ver más detalles
Betacoronavirus/genética, Infecciones por Coronavirus/genética, Neumonía Viral/genética, Pandemias/prevención & control, Comunicación en Salud, Mutación/genética, COVID-19
What causes a virus to change?
COVID-19 vaccines
When a virus is widely circulating in a population and causing many infections, the likelihood of the virus mutating increases. The more opportunities a virus has to spread, the more it replicates – and the more opportunities it has to undergo changes.
Ver más detalles
Betacoronavirus/genética, Infecciones por Coronavirus/genética, Neumonía Viral/genética, Pandemias/prevención & control, Comunicación en Salud, Mutación/genética, COVID-19
Vaccines are life-saving interventions
COVID-19 vaccines
In the context of COVID-19 vaccine research, Dr Soumya Swaminathan, WHO Chief Scientist, talks about the pivotal role that vaccines have played in saving millions of lives. She also explains the rigorous process that vaccines must go through before being certified as safe.
Ver más detalles
Betacoronavirus/inmunología, Infecciones por Coronavirus/inmunología, Neumonía Viral/inmunología, Pandemias/prevención & control, Comunicación en Salud, Vacunas Virales/inmunología, COVID-19
The road to a COVID-19 vaccine
COVID-19 vaccines
Developing a vaccine is a long road full of checkpoints. Each phase designed to make sure it is both effective and safe. But with the whole world struggling to contain a pandemic, and unprecedented amounts of funding available, the road to finding the COVID-19 vaccine looks more like this.
Ver más detalles
Betacoronavirus/inmunología, Infecciones por Coronavirus/inmunología, Neumonía Viral/inmunología, Pandemias/prevención & control, Comunicación en Salud, Programas de Inmunización/organización & administración, Vacunas Virales/provisión & distribución, COVID-19